Charles L. Brown, III, MD, FACC

General Statement of Disclosure:

OWNERSHIP/PARTNERSHIP/PRINCIPAL: opus medical(NONE), BioStar Ventures(NONE), global genomics group(NONE), HeartBeam(NONE) OTHER FINANCIAL BENEFIT: CVRx(NONE)

View Full Disclosure